**Question:** About biotransformation, the following statement is untrue.

A. Biotransformation is the process of converting a substance into another substance by enzymes.
B. Biotransformation mainly occurs in the liver and kidneys.
C. Biotransformation involves the breakdown of drugs to eliminate them from the body.
D. Biotransformation can lead to the production of toxic substances in the body.

**Correct Answer:** **Option D: Biotransformation can lead to the production of toxic substances in the body.**

**Core Concept:** Biotransformation refers to the process of converting a substance, such as drugs or toxins, into other compounds by the action of enzymes. This process plays a crucial role in drug disposition, as it helps in the elimination of drugs from the body, but also contributes to drug-drug interactions and potential toxic effects.

**Why the Correct Answer is Right:** Biotransformation is a crucial aspect of pharmacology, particularly in drug action and elimination. This process is primarily carried out by enzymes, particularly cytochrome P450 enzymes, which are responsible for breaking down drugs and toxins. This helps in eliminating these substances from the body, ensuring safe and effective drug therapy.

**Why Each Wrong Option is Incorrect:**

A. Although the statement mentions biotransformation, it does not address the concept of toxic substances being produced during this process.
B. Biotransformation occurs not only in the liver, but also in other organs such as the gastrointestinal tract, lungs, and skin.
C. While biotransformation does contribute to drug elimination, the statement oversimplifies the process by not mentioning the potential for toxic byproducts.
D. Biotransformation can indeed lead to the production of toxic substances when not properly regulated or when toxic byproducts are not efficiently eliminated from the body.

**Clinical Pearl:** Understanding the potential for toxic substance production during biotransformation is essential for safe and effective drug therapy. Clinicians must consider the risk of toxic effects when prescribing medications and monitor patients for potential adverse reactions. Additionally, knowledge of drug interactions that can affect biotransformation is crucial for safe prescribing.